Anemo Labs raises a £700k pre-seed round led by Zinc and SFC Capital to build electronic nose that detects disease signals in smell

Anemo Labs develops electronic nose hardware paired with AI models that detect and classify disease-related volatile organic compounds in urine. The platform is built for clinicians and individuals who need a non-invasive way to screen for disease, with early diagnostic validation running alongside clinical partners.